MST1/2调控先天免疫的功能和机制
收稿日期: 2017-02-28
修回日期: 2017-03-22
网络出版日期: 2017-06-28
基金资助
国家自然科学基金项目(81571617, 31300723, 81671572, 31422018);中科院分子细胞卓越中心成员先导B项目(XDB19000000);科技部重大科学研究项目(2016YFD0500207, 2016YFC0902200)
The roles and mechanisms of MST1/2 in the innate immune response
Received date: 2017-02-28
Revised date: 2017-03-22
Online published: 2017-06-28
Supported by
the National Natural Science Foundation of China(81571617, 31300723, 81671572, 31422018);the Strategic Priority Research Program of the Chinese Academy of Sciences Center for Excellence in Molecular Cell Science(XDB19000000);the Ministry of Science and Technology of China(2016YFD0500207, 2016YFC0902200)
Hippo信号通路通过一系列激酶级联反应,实现对细胞增殖、器官大小以及组织再生等方面的调控。其中,MST1/2是核心激酶Hippo蛋白在哺乳动物中的同源物,对于下游信号通路的激活至关重要。此外,MST1/2在细胞分化、形态和细胞骨架重排等方面也发挥重要作用。近期多项研究工作指出,MST1/2参与调控免疫T细胞的粘附、迁移、归巢和抑制性Treg细胞的成熟与功能,以及心肌细胞自噬等过程。有趣的是,这一功能是不依赖经典的Hippo信号通路的,被称为“非经典Hippo信号通路”。最新的研究结果揭示了MST1/2通过非经典Hippo信号通路调控先天免疫巨噬细胞对病原菌或病毒的免疫应答,包括巨噬细胞的吞噬、细胞因子(炎症因子、趋化因子、Ⅰ型干扰素等)和线粒体活性氧的产生,从而在机体抵抗细菌病毒感染、炎症相关癌症、动脉粥样硬化等疾病中发挥重要功能。本文对MST1/2调控先天免疫功能、相关分子机制和疾病进行了总结和讨论。
周欣,李伟芸,王红艳 . MST1/2调控先天免疫的功能和机制[J]. 遗传, 2017 , 39(7) : 642 -649 . DOI: 10.16288/j.yczz.17-066
The Hippo signaling pathway regulates cell proliferation, organ size and tissue regeneration through a series of kinase cascades. MST1/2 is the mammalian orthologue of the core kinase Hippo, which is crucial for the activation of downstream signaling. Additionally, MST1/2 has been reported to play important roles in cell differentiation, morphology and cytoskeleton reorganization. Recent evidence suggests that MST1/2 is involved in the regulation of T cell adhesion, migration, homing and Treg cell maturation and functions. Interestingly, these processes are not dependent on the canonical, but a non-canonical Hippo signaling pathway. More recent studies have revealed that MST1/2 mediates the innate immune response against pathogens or viruses, especially on macrophage phagocytosis as well as cytokines and ROS production. MST1/2 is associated with various diseases, such as bacterial or viral infection, inflammation-related cancer, and atherosclerosis. In this review, we summarize recent findings on the functions of MST1/2 in the innate immune response and inflammation-related diseases.
| [1] | Varelas X. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development, 2014, 141(8): 1614-1626. |
| [2] | Zhao B, Wei XM, Li WQ, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu JD, Li L, Zheng P, Ye KQ, Chinnaiyan A, Halder G, Lai ZC, Guan KL. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev, 2007, 21(21): 2747-2761. |
| [3] | Liu B, Zheng YG, Yin F, Yu JZ, Silverman N, Pan DJ. Toll receptor-mediated Hippo signaling controls innate immunity in Drosophila. Cell, 2016, 164(3): 406-419. |
| [4] | Zhang L. Control of growth and beyond: a special issue on Hippo signaling. Acta Biochim Biophys Sin (Shanghai), 2015, 47(1): 1. |
| [5] | Meng ZP, Moroishi T, Mottier-Pavie V, Plouffe S W, Hansen CG, Hong AW, Park HW, Mo JS, Lu WQ, Lu SC, Flores F, Yu FX, Halder G, Guan KL. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun, 2015, 6: 8357. |
| [6] | Wang GC, Lu X, Dey P, Deng PN, Wu CC, Jiang S, Fang ZN, Zhao K, Konaparthi R, Hua SJ, Zhang JH, Li-Ning-Tapia EM, Kapoor A, Wu CJ, Patel NB, Guo ZL, Ramamoorthy V, Tieu TN, Heffernan T, Zhao D, Shang XY, Khadka S, Hou PP, Hu BL, Jin EJ, Yao WT, Pan XL, Ding ZH, Shi YX, Li LR, Chang Q, Troncoso P, Logothetis CJ, McArthur MJ, Chin L, Wang YA, DePinho RA. Targeting YAP-dependent MDSC infiltration impairs tumor progression. Cancer Discov, 2016, 6(1): 80-95. |
| [7] | Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe- Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ, Camargo FD. Hippo pathway activity influences liver cell fate. Cell, 2014, 157(6): 1324-1338. |
| [8] | Harvey KF, Zhang MX, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer, 2013, 13(4): 246-257. |
| [9] | Renner O, Fominaya J, Alonso S, Blanco-Aparicio C, Leal JFM, Carnero A. MST1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. Carcinogenesis, 2007, 28(7): 1418-1425. |
| [10] | Bernascone I, Martin-Belmonte F. Crossroads of Wnt and Hippo in epithelial tissues. Trends Cell Biol, 2013, 23(8): 380-389. |
| [11] | Kim M, Jho EH. Cross-talk between Wnt/β-catenin and Hippo signaling pathways: a brief review. Bmb Rep, 2014, 47(10): 540-545. |
| [12] | Taniguchi K, Wu LW, Grivennikov SI, de Jong PR, Lian I, Yu FX, Wang KP, Ho SB, Boland BS, Chang JT, Sandborn WJ, Hardiman G, Raz E, Maehara Y, Yoshimura A, Zucman-Rossi J, Guan KL, Karin M. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature, 2015, 519(7541): 57-62. |
| [13] | Ling P, Lu TJ, Yuan CJ, Lai MD. Biosignaling of mammalian Ste20-related kinases. Cell Signal, 2008, 20(7): 1237-1247. |
| [14] |